CRIS Current Research Information System

MURATORI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.703
AS - Asia 7.376
EU - Europa 5.387
SA - Sud America 438
AF - Africa 406
OC - Oceania 24
Totale 22.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.583
VN - Vietnam 2.122
CN - Cina 1.919
SG - Singapore 1.852
GB - Regno Unito 1.284
IT - Italia 1.031
DE - Germania 735
SE - Svezia 616
HK - Hong Kong 421
FR - Francia 350
IN - India 338
BR - Brasile 290
RU - Federazione Russa 274
UA - Ucraina 268
IE - Irlanda 176
BD - Bangladesh 151
NL - Olanda 147
JP - Giappone 138
KR - Corea 130
FI - Finlandia 108
ZA - Sudafrica 103
EE - Estonia 86
CI - Costa d'Avorio 78
CH - Svizzera 72
TG - Togo 72
SC - Seychelles 64
AR - Argentina 63
CA - Canada 56
PH - Filippine 45
BG - Bulgaria 42
AT - Austria 37
TR - Turchia 34
ID - Indonesia 33
MX - Messico 33
TH - Thailandia 33
JO - Giordania 32
PL - Polonia 32
EC - Ecuador 29
IQ - Iraq 27
BE - Belgio 22
NG - Nigeria 22
TW - Taiwan 17
AU - Australia 16
PK - Pakistan 16
RO - Romania 16
GR - Grecia 15
SA - Arabia Saudita 15
HR - Croazia 14
CL - Cile 13
ES - Italia 13
MA - Marocco 13
EG - Egitto 10
MY - Malesia 10
PY - Paraguay 10
TN - Tunisia 10
VE - Venezuela 10
LT - Lituania 9
KE - Kenya 8
PT - Portogallo 8
CO - Colombia 7
DZ - Algeria 7
IR - Iran 7
NZ - Nuova Zelanda 7
UY - Uruguay 6
UZ - Uzbekistan 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
SK - Slovacchia (Repubblica Slovacca) 5
AO - Angola 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
JM - Giamaica 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AL - Albania 3
BO - Bolivia 3
GH - Ghana 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
ET - Etiopia 2
FK - Isole Falkland (Malvinas) 2
LU - Lussemburgo 2
LV - Lettonia 2
MT - Malta 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
Totale 22.310
Salva come PNG Salva come JPEG
Città #
Singapore 1.255
Southend 1.105
Fairfield 928
Ashburn 867
Dong Ket 564
Chandler 552
San Jose 495
Seattle 440
Woodbridge 436
Houston 411
Santa Clara 397
Hong Kong 395
Ho Chi Minh City 386
Wilmington 376
Hefei 330
Cambridge 325
Hanoi 318
Princeton 258
Ann Arbor 219
Beijing 214
Boardman 175
Dublin 175
Jacksonville 170
Bologna 135
Lauterbourg 130
Nanjing 129
Los Angeles 116
Tokyo 116
Council Bluffs 115
Seoul 110
Padova 107
Westminster 105
Berlin 100
Helsinki 93
Frankfurt am Main 88
Jinan 83
Milan 81
Abidjan 78
New York 77
Lomé 72
Da Nang 70
Buffalo 69
Dallas 67
Shenyang 59
Haiphong 57
Bern 56
Saint Petersburg 55
San Diego 48
Rome 46
Changsha 45
Redondo Beach 41
Sofia 40
Hebei 39
Guangzhou 38
Shanghai 38
Des Moines 37
Phoenix 37
São Paulo 37
Bremen 36
Mülheim 36
Turin 34
Tianjin 33
Amman 32
Bengaluru 32
Nanchang 32
Zhengzhou 28
Hangzhou 26
London 26
Nuremberg 23
Orem 23
Munich 22
Vienna 22
Brussels 21
Chicago 21
Haikou 21
Hải Dương 21
Medford 21
Taiyuan 21
Abeokuta 20
Dearborn 20
San Francisco 20
Warsaw 20
Ningbo 19
Toronto 19
Bühl 18
Jakarta 18
Mahé 18
Norwalk 18
Verona 18
Can Tho 17
Falkenstein 17
Jiaxing 17
Taizhou 17
Washington 17
Falls Church 16
Moscow 16
Ninh Bình 16
Yubileyny 16
Biên Hòa 15
Chengdu 15
Totale 14.323
Salva come PNG Salva come JPEG
Nome #
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence 379
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 299
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 279
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 277
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 258
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 256
Clinical and serological profile of primary biliary cirrhosis in men. 246
Antinuclear antibodies in COVID 19 244
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 238
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 238
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. 238
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 236
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 232
Autoimmune liver disease and concomitant extrahepatic autoimmune disease 232
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 230
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. 226
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 226
Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients 215
Anti-actin IgA antibodies in severe coeliac disease 215
SPECIFICITY OF ANTI-SP100 ANTIBODY FOR PRIMARY BILIARY CIRRHOSIS. 213
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 210
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset 206
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis 205
Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy 202
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 201
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 200
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 200
Autoantibodies in Autoimmune Hepatitis 199
Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study 198
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 196
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 194
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 191
Acute liver injury and anorexia nervosa: A case report 190
Diagnosis and therapy of autoimmune hepatitis. 190
Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype 187
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 187
Autoimmune liver disease 2007. 186
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 185
Blood-Based Non-Invasive Tests of Hepatic Fibrosis in Autoimmune Hepatitis: Application among Selected Patients Leads to Higher Accuracy 183
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 183
Autoimmune hepatitis in Italy: the Bologna experience. 180
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. 179
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 178
Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. 177
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 177
Antitransglutaminase antibodies and giardiasis 176
ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study 175
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value 175
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 175
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 174
Primary biliary cirrhosis specific anti-nuclear antibodies in patients from Spain. 172
Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis. 172
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 172
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 171
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 170
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 169
PML NUCLEAR BODY COMPONENT SP140 IS A NOVEL AUTOANTIGEN IN PRIMARY BILIARY CIRRHOSIS. 168
Specific antinuclear reactivities in primary biliary cirrhosis 167
DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSIS. 165
Standardization of Autoantibody Testing in Autoimmune Hepatitis 164
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 163
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 162
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. 160
Diagnostic approach to autoimmune hepatitis 160
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 159
Celiac disease in autoimmune cholestatic liver disorders 159
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 157
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 156
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51 153
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. 152
HCV and autoimmunity. 151
Autoimmune liver disease serology in acute hepatitis E virus infection 151
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 149
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. 147
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 147
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 147
Regulatory T cell defects in adult autoimmune hepatitis. 146
Diagnosis of primary biliary cholangitis in a "teen" male patient 146
Nuclear Envelope Protein Autoantibodies/Antilamin Autoantibodies (Chapter 26) 146
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. 143
Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis 143
Decompensated cirrhosis as presentation of LKM1/LC1 positive type 2 autoimmune hepatitis in adulthood. A rare clinical entity of difficult management 142
Two of them do it better: Novel serum biomarkers improve autoimmune hepatitis diagnosis 142
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. 142
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis 142
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 141
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 139
Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis. 139
Coronavirus disease associated immune thrombocytopenia: Causation or correlation? 136
Serum Smooth Muscle Antibodies (SMA). 135
Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting 135
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C 134
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. 134
Genetic distinction between autoimmune hepatitis in Italy and North America 133
Acute-on-chronic liver failure: A complex clinical entity in patients with autoimmune hepatitis 133
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 132
Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis 132
Autoantibodies to speckled protein family in primary biliary cholangitis 128
A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center 124
Hepatitis C and autoreactivity. 123
Totale 18.089
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021822 0 0 0 0 0 0 0 0 0 0 0 822
2021/20222.463 189 59 175 208 204 119 76 161 102 163 581 426
2022/20232.403 333 331 127 309 130 175 96 127 376 95 184 120
2023/2024736 48 111 51 68 53 115 39 66 21 43 62 59
2024/20253.123 171 449 323 250 545 170 184 88 64 183 111 585
2025/20267.374 534 696 616 560 793 405 653 170 1.648 634 394 271
Totale 22.707